Lochhead Paul, Chan Andrew T, Nishihara Reiko, Fuchs Charles S, Beck Andrew H, Giovannucci Edward, Ogino Shuji
Gastrointestinal Research Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.
1] Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA [2] Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Mod Pathol. 2015 Jan;28(1):14-29. doi: 10.1038/modpathol.2014.81. Epub 2014 Jun 13.
The term 'field effect' (also known as field defect, field cancerization, or field carcinogenesis) has been used to describe a field of cellular and molecular alteration, which predisposes to the development of neoplasms within that territory. We explore an expanded, integrative concept, 'etiologic field effect', which asserts that various etiologic factors (the exposome including dietary, lifestyle, environmental, microbial, hormonal, and genetic factors) and their interactions (the interactome) contribute to a tissue microenvironmental milieu that constitutes a 'field of susceptibility' to neoplasia initiation, evolution, and progression. Importantly, etiological fields predate the acquisition of molecular aberrations commonly considered to indicate presence of filed effect. Inspired by molecular pathological epidemiology (MPE) research, which examines the influence of etiologic factors on cellular and molecular alterations during disease course, an etiologically focused approach to field effect can: (1) broaden the horizons of our inquiry into cancer susceptibility and progression at molecular, cellular, and environmental levels, during all stages of tumor evolution; (2) embrace host-environment-tumor interactions (including gene-environment interactions) occurring in the tumor microenvironment; and, (3) help explain intriguing observations, such as shared molecular features between bilateral primary breast carcinomas, and between synchronous colorectal cancers, where similar molecular changes are absent from intervening normal colon. MPE research has identified a number of endogenous and environmental exposures which can influence not only molecular signatures in the genome, epigenome, transcriptome, proteome, metabolome and interactome, but also host immunity and tumor behavior. We anticipate that future technological advances will allow the development of in vivo biosensors capable of detecting and quantifying 'etiologic field effect' as abnormal network pathology patterns of cellular and microenvironmental responses to endogenous and exogenous exposures. Through an 'etiologic field effect' paradigm, and holistic systems pathology (systems biology) approaches to cancer biology, we can improve personalized prevention and treatment strategies for precision medicine.
“场效应”(也称为场缺陷、场癌化或场致癌作用)这一术语已被用于描述细胞和分子改变的一个区域,该区域易发生该区域内肿瘤的发展。我们探索了一个扩展的、综合的概念——“病因场效应”,它断言各种病因因素(包括饮食、生活方式、环境、微生物、激素和遗传因素的暴露组)及其相互作用(相互作用组)会导致一种组织微环境,这种微环境构成了肿瘤发生、演变和进展的“易感性场”。重要的是,病因场早于通常被认为表明存在场效应的分子畸变的获得。受分子病理流行病学(MPE)研究的启发,该研究考察病因因素在疾病过程中对细胞和分子改变的影响,一种以病因学为重点的场效应研究方法可以:(1)在肿瘤演变的所有阶段,拓宽我们在分子、细胞和环境水平上对癌症易感性和进展的探究视野;(2)涵盖肿瘤微环境中发生的宿主 - 环境 - 肿瘤相互作用(包括基因 - 环境相互作用);以及(3)有助于解释一些有趣的观察结果,例如双侧原发性乳腺癌之间以及同步性结直肠癌之间共享的分子特征,而在其间的正常结肠中不存在类似的分子变化。MPE研究已经确定了许多内源性和环境暴露,这些暴露不仅会影响基因组、表观基因组、转录组、蛋白质组、代谢组和相互作用组中的分子特征,还会影响宿主免疫力和肿瘤行为。我们预计,未来的技术进步将使能够检测和量化“病因场效应”的体内生物传感器得以开发,这种效应表现为细胞和微环境对内源性和外源性暴露的异常网络病理模式。通过“病因场效应”范式以及癌症生物学的整体系统病理学(系统生物学)方法,我们可以改进精准医学的个性化预防和治疗策略。